Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain
Schoemaker, H.; Boles, R.G.; Roeske, W.R.; Yamamura, H.I.
Proceedings of the Western Pharmacology Society 26: 219-224
1983
ISSN/ISBN: 0083-8969 PMID: 6310626 Document Number: 215158
Document emailed within 1 workday
Related Documents
Gould, R.J.; Murphy, K.M.; Snyder, S.H. 1984: Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine Molecular Pharmacology 25(2): 235-241Majewska, M.D.; Chuang, D.M. 1984: Modulation by calcium of gamma-aminobutyric acid (GABA) binding to GABAA and GABAB recognition sites in rat brain. Involvement of different mechanisms Molecular Pharmacology 25(3): 352-359
Ei-Fakahany, E.F.; Miller, E.R.; Abbassy, M.A.; Eldefrawi, A.T.; Eldefrawi, M.E. 1983: Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor Journal of Pharmacology and Experimental Therapeutics 224(2): 289-296
Mack, W.M.; Zimányi, I.; Pessah, I.N. 1992: Discrimination of multiple binding sites for antagonists of the calcium release channel complex of skeletal and cardiac sarcoplasmic reticulum Journal of Pharmacology and Experimental Therapeutics 262(3): 1028-1037
Lopes, H.F.; Silva, H.B.; Bellotti, G.; Pillegi, F. 1990: Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 54(3): 227-229
Sato, T.; Ono, H. 1981: Facilitation of Neuromuscular transmission by calcium antagonists, diltiazem, nifedipine and verapamil, in the dog Archives Internationales de Pharmacodynamie et de Therapie 249(2): 235-246
Sharkey, R.G.; Jover, E.; Couraud, F.; Baden, D.G.; Catterall, W.A. 1987: Allosteric modulation of neurotoxin binding to voltage-sensitive sodium channels by Ptychodiscus brevis toxin 2 Molecular Pharmacology 31(3): 273-278
Ebersole, B.J.; Gajary, Z.L.; Molinoff, P.B. 1988: Endogenous modulators of binding of [3H]nitrendipine in extracts of rat brain Journal of Pharmacology and Experimental Therapeutics 244(3): 971-976
Kiyomoto, A.; Sasaki, Y.; Odawara, A.; Morita, T. 1983: Inhibition of platelet aggregation by diltiazem. Comparison with verapamil and nifedipine and inhibitory potencies of diltiazem metabolites Circulation Research 52(2 Part 2): I115-I119
Ozawa, S.; Kimura, N. 1982: Calcium channel and prolactin release in rat clonal pituitary cells: effects of verapamil American Journal of Physiology 243(1): E68-E73
Alemà, S.; Bianconi, A.; Castellani, L.; Fasella, P. 1982: X-ray absorption spectroscopy (EXAFS and XANES) a structural tool for calcium binding proteins: effect of Mg2+ on Ca2+ binding sites of troponin-C Progress in Clinical and Biological Research 102 Pt C: 47-57
Slany, A.; Zezula, J.; Tretter, V.; Sieghart, W. 1995: Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type a receptors Molecular Pharmacology 48(3): 385-391
Olsen, R.W.; Bergman, M.O.; Van Ness, P.C.; Lummis, S.C.; Watkins, A.E.; Napias, C.; Greenlee, D.V. 1981: Gamma-Aminobutyric acid receptor binding in mammalian brain. Heterogeneity of binding sites Molecular Pharmacology 19(2): 217-227
Mel'nikova, N.P.; Timoshin, S.S. 1999: Effect od calcium channel blocker, verapamil on DNA synthesis and activity of nucleolar organizer in myocardial cells of newborn rats Biulleten' Eksperimental'noi Biologii i Meditsiny 127(6): 658-660
Van Rossum, D.; Ménard, D.P.; Fournier, A.; St-Pierre, S.; Quirion, R. 1994: Autoradiographic distribution and receptor binding profile of [125I]Bolton Hunter-rat amylin binding sites in the rat brain Journal of Pharmacology and Experimental Therapeutics 270(2): 779-787
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282
Hess, P.; Lansman, J.B.; Nilius, B.; Tsien, R.W. 1986: Calcium channel types in cardiac myocytes: modulation by dihydropyridines and beta-adrenergic stimulation Journal of Cardiovascular Pharmacology 8(Suppl 9): S11-S21
Rudijanto, A. 2010: Calcium channel blocker (diltiazem) inhibits apoptosis of vascular smooth muscle cell exposed to high glucose concentration through lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) pathway Acta Medica Indonesiana 42(2): 59-65
Brunello, N.; Rovescalli, A.C.; Riva, M.; Racagni, G. 1986: Lack of serotonergic modulation on 3H-imipramine binding sites in basal conditions and during prolonged treatment with desmethylimipramine Psychopharmacology Bulletin 22(3): 931-936
Heltzel, J.A.; Vogel, W.H. 1983: The distribution of serotonin binding sites: a comparison of 3H-serotonin binding in membrane preparations of rat gut and rat brain Advances in Biochemical Psychopharmacology 37: 385-394